New Treatments in Breast Cancer: The Role of Immunotherapy in 2026
Molecular selection: assignment criteria and innovative approaches The choice of therapeutic tactics is not possible today without deep molecular profiling. Immunotherapy for breast cancer patients is prescribed based on PD-L1 biomarkers. This approach ensures maximum accuracy of the intervention, minimizing the systemic toxicity characteristic of classical chemotherapy. A special place in the modern hierarchy of methods […]
New Treatments in Breast Cancer: The Role of Immunotherapy in 2026 Read More »









